Mostrando 10 resultados de: 30
Filtros aplicados
Subtipo de publicación
Other(30)
Publisher
The American Association for Cancer Research(11)
American Association for Cancer Research(3)
American Society of Clinical Oncology(2)
ELSEVIER SCI LTD(2)
Cell Press(1)
Área temáticas
Enfermedades(27)
Farmacología y terapéutica(19)
Medicina y salud(4)
Bioquímica(3)
Biología(1)
Área de conocimiento
Farmacología(9)
Bioquímica(5)
Descubrimiento de fármacos(4)
Biología(1)
Biología molecular(1)
Origen
google(30)
An evaluation of siRNA screening in identification of targets in PTEN deficient tumor cells.
OtherAbstract: e13569 Background: PTEN is frequently lost in cancer cells through genetic mutation or epigenetic siPalabras claves:Autores:Harrison CastroFuentes:googleAntitumor activity of the novel oral highly selective Wee1 inhibitor Debio 0123
OtherAbstract: Background: The Wee1 tyrosine kinase is activated upon DNA damage and regulates the G2-M cell cyclePalabras claves:Autores:Harrison CastroFuentes:googleA PROGNOSTIC SIGNATURE FOR PTEN-DEFICIENT GLIOBLASTOMAS
OtherAbstract: A PROGNOSTIC SIGNATURE FOR PTEN-DEFICIENT GLIOBLASTOMAS — Queen's University Belfast Skip to main naPalabras claves:Autores:Harrison CastroFuentes:googleAKT inhibitor compounds for treatment of cancer
OtherAbstract: The present invention relates to compounds that are useful as inhibitors of the activity of one or mPalabras claves:Autores:Harrison CastroFuentes:googleDevelopment and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP
OtherAbstract: Evasion of cell death is a major cause of resistance to anti-cancer therapies, making proteins thatPalabras claves:Autores:Harrison CastroFuentes:googleDevelopment of FK506-binding protein like and its peptide derivatives as antiangiogenics and antimetastatic therapeutics for the treatment of cancer
OtherAbstract: Development of FK506-binding protein like and its peptide derivatives as antiangiogenics and antimetPalabras claves:Autores:Harrison CastroFuentes:googleCyclohexyl sulphones for treatment of cancer
OtherAbstract: Nickoloff, BJ et al. Oncogen, vol. 22, pp. 6598-6608 (2004),“Notch signaling as a therapeutic targetPalabras claves:Autores:Harrison CastroFuentes:googleDelivering a research‐enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program
OtherAbstract: The last 20 years have seen significant advances in cancer care in Northern Ireland, leading to measPalabras claves:Autores:Harrison CastroFuentes:googleApoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling
OtherAbstract: In this report, inhibitors of the γ-secretase enzyme have been exploited to characterize the antiproPalabras claves:Autores:Harrison CastroFuentes:googleAbstract B17: Development of novel, potent orally available Wee1 inhibitors with robust antitumor efficacy in vivo
OtherAbstract: Wee1 is a tyrosine kinase that phosphorylates cyclin-dependent kinase 1 (CDC2) to inactive the CDC2/Palabras claves:Autores:Harrison CastroFuentes:google